Klaas Schildknegt

965 total citations
25 papers, 738 citations indexed

About

Klaas Schildknegt is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Klaas Schildknegt has authored 25 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Klaas Schildknegt's work include Chemical Reactions and Isotopes (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Biological Evaluation (4 papers). Klaas Schildknegt is often cited by papers focused on Chemical Reactions and Isotopes (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Biological Evaluation (4 papers). Klaas Schildknegt collaborates with scholars based in United States, United Kingdom and Sweden. Klaas Schildknegt's co-authors include Jeffrey Aubé, Rajesh Iyengar, Ken S. Feldman, Konstantinos A. Agrios, Gregory L. Milligan, Pankaj Desai, Craig J. Mossman, Aruna Sambandam, R. Scott Obach and Alfin D. N. Vaz and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Klaas Schildknegt

24 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klaas Schildknegt United States	15	493	187	109	81	54	25	738
Carl Berthelette Canada	19	428 0.9×	200 1.1×	52 0.5×	60 0.7×	33 0.6×	25	705
Jeremy J. Edmunds United States	20	631 1.3×	427 2.3×	51 0.5×	64 0.8×	39 0.7×	54	1.1k
Carsten Schmeck Germany	15	312 0.6×	309 1.7×	51 0.5×	43 0.5×	41 0.8×	26	759
Leonard L. Winneroski United States	14	399 0.8×	492 2.6×	48 0.4×	44 0.5×	39 0.7×	22	901
Satya Prakash Panda United States	18	270 0.5×	247 1.3×	208 1.9×	52 0.6×	38 0.7×	31	803
Robert E. Zelle United States	13	561 1.1×	326 1.7×	54 0.5×	51 0.6×	52 1.0×	17	816
Rhys Salter United States	11	162 0.3×	117 0.6×	68 0.6×	117 1.4×	34 0.6×	31	380
Jaclyn L. Henderson United States	12	642 1.3×	230 1.2×	113 1.0×	34 0.4×	19 0.4×	13	1.0k
Jason Xiang United States	18	621 1.3×	171 0.9×	60 0.6×	91 1.1×	27 0.5×	23	916
David Jonathan Bennett United Kingdom	13	509 1.0×	216 1.2×	25 0.2×	121 1.5×	79 1.5×	24	865

Countries citing papers authored by Klaas Schildknegt

Since Specialization

Citations

This map shows the geographic impact of Klaas Schildknegt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaas Schildknegt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaas Schildknegt more than expected).

Fields of papers citing papers by Klaas Schildknegt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaas Schildknegt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaas Schildknegt. The network helps show where Klaas Schildknegt may publish in the future.

Co-authorship network of co-authors of Klaas Schildknegt

This figure shows the co-authorship network connecting the top 25 collaborators of Klaas Schildknegt. A scholar is included among the top collaborators of Klaas Schildknegt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaas Schildknegt. Klaas Schildknegt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheruvu, N., Esther van Duijn, Ioana Barbu, et al.. (2023). The Metabolism of Lufotrelvir, a Prodrug Investigated for the Treatment of SARS-COV2 in Humans Following Intravenous Administration. Drug Metabolism and Disposition. 51(10). 1419–1427. 5 indexed citations

Czeskis, Boris A., Charles S. Elmore, Anthony R. Haight, et al.. (2019). Deuterated active pharmaceutical ingredients: A science‐based proposal for synthesis, analysis, and control. Part 1: Framing the problem. Journal of Labelled Compounds and Radiopharmaceuticals. 62(11). 690–694. 21 indexed citations

Zhang, Lei, Christopher R. Butler, Kevin Maresca, et al.. (2019). Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity. Journal of Medicinal Chemistry. 62(18). 8532–8543. 19 indexed citations

Sawant‐Basak, Aarti, R. Scott Obach, Angela C. Doran, et al.. (2018). Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction. Drug Metabolism and Disposition. 46(7). 934–942. 6 indexed citations

Zhang, Lei, Laigao Chen, Jason K. Dutra, et al.. (2018). Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain. Journal of Medicinal Chemistry. 61(8). 3296–3308. 15 indexed citations

Raje, Sangeeta, Ernesto Callegari, Vaishali Sahasrabudhe, et al.. (2018). Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin. Clinical and Translational Science. 11(4). 405–411. 33 indexed citations

Ballard, T. Eric, Manoj B. Charati, Justin D. Cohen, et al.. (2016). Determination of Antibody–Drug Conjugate Released Payload Species Using Directed in Vitro Assays and Mass Spectrometric Interrogation. Bioconjugate Chemistry. 27(7). 1645–1654. 26 indexed citations

Srirajan, Vaidyanathan, et al.. (2012). Asymmetric syntheses of radioactive and stable isotope‐labeled β‐amino acids. Journal of Labelled Compounds and Radiopharmaceuticals. 55(5). 166–170. 2 indexed citations

Sharma, Raman, Timothy J. Strelevitz, Hongying Gao, et al.. (2011). Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs. Drug Metabolism and Disposition. 40(3). 625–634. 81 indexed citations

10.

Kamel, Amin, et al.. (2010). Metabolism, Pharmacokinetics, and Excretion of the 5-Hydroxytryptamine1B Receptor Antagonist Elzasonan in Humans. Drug Metabolism and Disposition. 38(11). 1984–1999. 7 indexed citations

11.

Schildknegt, Klaas, et al.. (2010). 10th international symposium on the synthesis and applications of isotopes and isotopically labelled compounds—applications of isotopes in organic and bioorganic reaction mechanisms Session 4, Wednesday, June 17, 2009. Journal of Labelled Compounds and Radiopharmaceuticals. 53(5-6). 275–282.

12.

Kalgutkar, Amit S., Deepak Dalvie, Jiri Aubrecht, et al.. (2007). Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation. Drug Metabolism and Disposition. 35(6). 848–858. 36 indexed citations

13.

Schildknegt, Klaas, et al.. (2007). An efficient large‐scale synthesis of 1H‐indazole‐[3‐¹⁴C]carboxylic acid. Journal of Labelled Compounds and Radiopharmaceuticals. 50(7). 675–678. 2 indexed citations

14.

Iyengar, Rajesh, et al.. (2005). Revisiting a Classic Approach to the Aspidosperma Alkaloids: An Intramolecular Schmidt Reaction Mediated Synthesis of (+)-Aspidospermidine. The Journal of Organic Chemistry. 70(26). 10645–10652. 87 indexed citations

15.

Iyengar, Rajesh, Klaas Schildknegt, & Jeffrey Aubé. (2000). Regiocontrol in an Intramolecular Schmidt Reaction: Total Synthesis of (+)-Aspidospermidine. Organic Letters. 2(11). 1625–1627. 83 indexed citations

16.

Reiter, Lawrence A., Brian P. Jones, Klaas Schildknegt, et al.. (2000). The Synthesis of an Aminohexyl-containing Analog of the Chromanol Leukotriene B4 Receptor Antagonist CP-195543: A Scaffold for the Preparation of Derivatized Analogs. Heterocycles. 53(8). 1713–1713. 1 indexed citations

17.

Schildknegt, Klaas, Konstantinos A. Agrios, & Jeffrey Aubé. (1998). Mannich reactions using benzyl azide as a latent N-(phenylamino)methylating agent. Tetrahedron Letters. 39(42). 7687–7690. 17 indexed citations

18.

Feldman, Ken S., et al.. (1995). Preparation of Five-Membered Nitrogen-Containing Heterocycles via [Three-Atom + Two-Atom] Combination of Tosylamide Anions with Phenyl(propynyl)iodonium Triflate. The Journal of Organic Chemistry. 60(24). 7722–7723. 33 indexed citations

19.

Feldman, Ken S. & Klaas Schildknegt. (1994). Thioamide and Thioester Cyclopentane Synthesis via Trimethyltin Radical Catalyzed Alkenylation of Substituted (Thiocarbonyl)cyclopropanes. The Journal of Organic Chemistry. 59(5). 1129–1134. 10 indexed citations

20.

Itô, Hiroshi, Klaas Schildknegt, & Eugene A. Mash. (1991). <title>Negative chemical amplification resist systems based on polyhydroxystyrenes and N-substituted imides or aldehydes</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1466. 408–418. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact